患者的数字双胞胎:一个队列匹配解释
Nilmini Wickramasinghe1,2,3, Nalika Ulapane1, Kalpana Raghunathan1
1School of Computing, Engineering & Mathematical Sciences, La Trobe University, Melbourne, Australia.
Studies in health technology and informatics
|August 8, 2025
概括
数字双胞胎 (DTs) 创建个性化的患者模型,以获得更好的医疗保健. 本研究使用DTs进行队列匹配,以帮助精确的治疗规划,特别是在三阴性乳腺癌免疫治疗中.
科学领域:
- 生物医学信息学 生物医学信息学
- 计算医学是一种计算医学.
- 数字健康数字健康
背景情况:
- 数字双胞胎 (DTs) 是物理实体的虚拟表示,在医疗保健中有新兴的应用.
- 特定于患者的DTs提供了为个性化治疗提供临床决策支持工具的潜力.
- 从健康数据中获得洞察力对于定制医疗干预至关重要.
研究的目的:
- 探索数字双胞胎在医疗保健中的个性化治疗策略的使用.
- 开发一种使用患者数据支持临床决策的队列匹配方法.
- 将这种方法应用于针对三阴性乳腺癌的免疫疗法治疗计划.
主要方法:
- 利用数字双胞胎技术创建虚拟患者模型.
- 实施队列匹配算法,从历史数据中识别类似的患者个人资料.
- 案例研究重点是针对三阴性乳腺癌的免疫疗法.
主要成果:
- 通过队列匹配来实现患者个性化的框架.
- 成功地将数字双胞胎方法应用于特定的癌症治疗场景.
- 确定了在复杂的治疗规划中加强决策支持的潜力.
结论:
- 数字双胞胎对推进个性化医学具有重大前景.
- 通过DTs进行队列匹配可以提高治疗建议的准确性.
- 这种方法显示出在瘤学中优化免疫疗法策略的潜力.
相关概念视频
Analysis of Population Pharmacokinetic Data
385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385
Crossover Experiments
3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K


